COMMUNIQUÉS West-GlobeNewswire

Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
18/09/2026
If approved, Sogroya® (somapacitan) would be the first and only growth hormone treatment approved for idiopathic short stature in the EU, providing a much-needed treatment option for children and their families affected [...]
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
18/09/2026
Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus demonstrated non- [...]
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
18/09/2026
POMPANO BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and [...]
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
18/09/2026
Strengthened balance sheet with successful completion of upsized $168.3 million initial public offering Announced FDA Fast Track designation for BH-30643 for the treatment of advanced EGFR C797S-positive NSCLC SAN DIEGO [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
BEDFORD, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
CHMP recommends approval of Johnson & Johnson’s TECVAYLI®▼ (teclistamab) in relapsed/refractory multiple myeloma after at least one prior therapy
18/09/2026
CHMP recommendation follows positive Phase 3 study results, marking the second Phase 3 study to demonstrate benefit with a TECVAYLI ® -based regimen in the second-line setting 1 ,2 Results demonstrated significantly [...]
Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
18/09/2026
- FDA approval represents a monumental milestone for patients with MPS IIIA and validates Abeona’s foundational R&D and clinical development efforts - - Ultragenyx successfully brought a life-changing therapy across [...]
Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer
18/09/2026
Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the [...]
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
18/09/2026
Investigational New Drug application planned for submission to the U.S. FDA in the fourth quarter of 2026, advancing the Company’s regulatory path toward NDA filing for gout program XRx-026 CALGARY, Alberta, Sept. 18, [...]
TOMI Environmental Solutions Reports Accelerating Growth in SteraMist Service Revenue
18/09/2026
Year-to-date SteraMist iHP Service and Support sales of approximately $1.7 million reflects a roughly 31% increase over full-year 2025, underscoring the growing recurring-revenue contribution of TOMI's contracted [...]
Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administration
18/09/2026
Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administration PARIS, FRANCE, 18 SEPTEMBRE 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd’hui la cooptation de Mariette Finet en qualité d’ [...]
Ipsen appoints Mariette Finet to its Board of Directors
18/09/2026
Ipsen appoints Mariette Finet to its Board of Directors PARIS, FRANCE, 18 SEPTEMBER 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Mariette Finet as a Director to its Board of Directors, [...]
DXS INTERNATIONAL PLC (AQSE: DXSP): Timing of FY Results to 30 April 2026
18/09/2026
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union ( [...]
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
18/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of [...]
Immumax Expands Global Access to the E-Tapper to Empower Natural Health Management from Home
18/09/2026
HONG KONG, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Immumax, a pioneer in alternative health and wellness solutions, has announced the international expansion of its online training and consultation services. Focused on [...]
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
18/09/2026
SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
17/09/2026
PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
BioTech Social Announces Advisory Board to Advance Financial Innovation for Life Science Companies
18/09/2026
BETHESDA, MD, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Experienced leaders across biotechnology, finance, technology, patient engagement, communications, and company building will advise BSI as it builds financial [...]
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
17/09/2026
The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development [...]

Pages